Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. - Wikidata - awgldk - TriplyDB

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

http://www.wikidata.org/entity/Q46390942

about

BRCAness: finding the Achilles heel in ovarian cancer Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention"Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence Association of myeloperoxidase with ovarian cancer.Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency.Ovarian cancer survival by tumor dominance, a surrogate for site of origin.Prediction of BRCA1 germline mutation status in women with ovarian cancer using morphology-based criteria: identification of a BRCA1 ovarian cancer phenotype.BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas.Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers.Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.High-grade serous carcinoma of tubo-ovarian origin: recent developments.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma.High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.Cancer of the ovary, fallopian tube, and peritoneum.Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.Genomic signatures of BRCA1 but not BRCA2 associated high-grade serous carcinoma resemble basal-like breast cancer.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.The roles of pathology in targeted therapy of women with gynecologic cancers.How can molecular abnormalities influence our clinical approach.Whole-genome characterization of chemoresistant ovarian cancer.[Grading of gynecological tumors : Current aspects].[Hereditary breast and ovarian cancer].Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity

P2860

Q24630872-C78E8867-8082-4151-A544-9EC478A1205E Q26740622-2892A24A-4918-4A54-9D1C-CC59112727CB Q26780387-10523783-8E87-40F6-820A-6BE6963313E1 Q26783551-28268C61-B904-44AF-B606-475F408DBC7F Q26852127-57C391CE-52FB-4E1B-BE13-DD798BE4D653 Q27025315-538BE053-D758-4871-A9C4-7FA9E65CE24F Q30250107-5F91316D-6A4C-4FA7-9128-1942871C2178 Q33689246-A309CFD2-0FED-4DB7-B8CE-2C4DE222B753 Q33748623-DEC9DD26-9174-4217-9183-FE12CE7978B7 Q35104225-EFDF9E85-FCB6-4DDC-B622-FED0BBB79965 Q36032691-A75CB69F-9AE0-4447-93B4-A4A69325675F Q36173170-A364DFE4-E1EA-4531-8066-7199CA724846 Q36493279-9C48ABE5-DF50-4D80-88AC-5C5E595DADDC Q36889676-1C11BDD6-5EB5-4C74-B0DB-DAA3857CB683 Q37046405-751D575B-77E2-48AF-A74F-F6D1E57470CF Q37146082-44EC5F44-7C0F-4B78-B305-112CBB02CF4E Q37196721-02193541-91CA-4E0B-9A6C-4DE3E35DF706 Q37540704-14CD85BA-3DFF-448C-94D9-DA873C421F54 Q37558633-113C568C-D0BD-43AE-8AAE-AC9689C1B0F9 Q37639332-B7D81050-7465-4D01-A04D-04504D559DDB Q38067436-7729A5E3-B819-4D18-9CDD-5241E7B38BD8 Q38687061-72949CB7-09B9-405C-94B5-14F839831C46 Q38787667-407CC30F-FA9A-44CA-A75E-D88EB9D64E2D Q38975570-2E4916EA-2BFD-47E7-9948-2DBD4CBC7E57 Q39382941-BA7CB725-3A76-472B-9D1B-ED908C9D582A Q41167815-E69C0889-05FE-4C93-AC67-AF8073D00849 Q41266914-0A4F1179-3C31-4482-8A8C-C47FDD05A997 Q41557623-3AE2317C-779C-45A5-B585-A327504418F1 Q42446598-19E02F5D-857B-40B9-8685-5C562E55D752 Q46540302-D0778D1C-4593-4B89-8551-AE36DA923538 Q48556357-2D2DEDEA-D7FB-4A89-A219-78B9FA5F9E37 Q49645276-46EEF293-99EE-488F-80FE-CF7DF7E9D403 Q49896005-C5CA12B8-5656-4C4E-B767-0C0AC941234F Q50272478-A6B1CC18-E7FB-412F-8EDB-015EFF84A4CE Q52861155-921DB62C-B65A-4285-A830-0BF4459F9B2C Q53738265-C2DFDDEC-E93A-4E66-983D-3D4FD695DBD7 Q57137351-87D822E3-00C6-40F2-9BB4-2D6E3DB86CAF Q58698836-2978FDF0-BEFD-4925-BCF5-EEC573434CB9

P2860

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

http://www.wikidata.org/entity/Q46390942

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@en

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@nl

type

label

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@en

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@nl

prefLabel

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@en

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@nl

P1433

Q46390942-18A0C03B-1C3D-44D4-978F-C76736DAFDC8

P1476

Q46390942-06F97EF4-B6D0-420B-AFD1-3EB45983D5E7

P2093

Q46390942-007EA1B5-15A3-4700-8578-CF5C51567CDC

Q46390942-238A397F-D782-4E07-A53F-122FBCA539BC

Q46390942-5FEAD94B-546E-4284-B845-D1D61D604309

Q46390942-69F50912-F300-4057-A147-CAB267A0C310

Q46390942-6E54BE31-0598-4E2C-BE0B-0C2C1068FE3F

P2860

Q46390942-02F82AE9-8420-4067-8EF0-F6DF8233F443

Q46390942-28307E00-97E2-4ACF-BE0F-9F8E5234BBE4

Q46390942-3477903D-E85A-4E2D-A600-C92819AF2DB8

Q46390942-3669B796-5C48-4139-890A-ED74E2981C01

Q46390942-3B0BC793-563D-4661-9A77-0A642F153500

Q46390942-3C69F508-6B66-43C5-B5B0-8E34105EF418

Q46390942-432E476B-9C3A-4E80-9A87-30DCC08BE2A1

Q46390942-58A451B3-65F9-416E-96B6-3FE9D685E77F

Q46390942-6B29BF2B-9FC3-4CFB-B7E6-EBB8402631ED

Q46390942-6BCD70F0-5166-45D5-9374-122536FE869B

P2888

Q46390942-41B947CA-1303-4B45-97FE-ED00FD2104A4

P304

Q46390942-DB2B04F2-463D-4C4B-BA76-1CAA57F89665

P31

Q46390942-E669D8BE-E61C-4B11-BF5D-6594FEC0F22C

P356

Q46390942-83A912EE-936E-44F6-B9D6-25F9D2825F14

P433

Q46390942-EC39BD0E-3CE1-491A-98EE-38754D609D01

P478

Q46390942-F9994F8C-E2A3-4A9F-ADE3-291EB1C45FB3

P50

Q46390942-3F12BAF3-41B3-4C81-91CF-558F84B0F25D

Q46390942-A4CD1445-E81E-4EF9-802F-A29A950BD5D7

Q46390942-B6C566E8-D83A-43E5-B90C-0F851A8EB664

P577

Q46390942-F4618375-266B-4459-B107-E40BCDF63BBA

P5875

Q46390942-8DD867F0-EE88-486B-943C-56A02998DB78

P698

Q46390942-3C420A79-FCF9-4E33-9934-0FFD192C305A

P356

MODPATHOL.2011.183

P1433

Modern Pathology

P1476

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.

@en

P2093

David R Spriggs

http://www.w3.org/2001/XMLSchema#string

Douglas A Levine

http://www.w3.org/2001/XMLSchema#string

Guangming Han

http://www.w3.org/2001/XMLSchema#string

Karuna Garg

http://www.w3.org/2001/XMLSchema#string

Narciso Olvera

http://www.w3.org/2001/XMLSchema#string

P2860

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Integrated genomic analyses of ovarian carcinoma

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Lack of HIN-1 methylation defines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA1-linked tumors.

P2888

modpathol.2011.183

P304

625-636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2011.183

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Soslow

P577

2011-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51919283

http://www.w3.org/2001/XMLSchema#string

P698

22193042

http://www.w3.org/2001/XMLSchema#string